Abstract
Abstract
Objectives
This retrospective single-center analysis aimed to evaluate whether artificial intelligence can detect type 2 diabetes mellitus by evaluating the pectoral muscle on digital breast tomosynthesis (DBT).
Material method
An analysis of 11,594 DBT images of 287 consecutive female patients (mean age 60, range 40–77 years) was conducted using convolutional neural networks (EfficientNetB5). The inclusion criterion was left-sided screening images with unsuspicious interpretation who also had a current glycosylated hemoglobin A1c (HBA1c) % value. The exclusion criteria were inadequate imaging, history of breast cancer, and/or diabetes mellitus. HbA1c values between 5.6 and 6.4% were categorized as prediabetic, and those with values ≥ 6.5% were categorized as diabetic. A recorded HbA1c ≤ 5.5% served as the control group. Each group was divided into 3 subgroups according to age. Images were subjected to pattern analysis parameters then cropped and resized in a format to contain only pectoral muscle. The dataset was split into 85% for training and 15% for testing the model’s performance. The accuracy rate and F1-score were selected as performance indicators.
Results
The training process was concluded in the 15th epoch, each comprising 1000 steps, with an accuracy rate of 92% and a loss of only 0.22. The average specificity and sensitivity for all 3 groups were 95%. The F1-score was 0.95. AUC-ROC was 0.995. PPV was 94%, and NPV was 98%.
Conclusion
Our study presented a pioneering approach, applying deep learning for the detection of diabetes mellitus status in women using pectoral muscle images and was found to function with an accuracy rate of 92%.
Critical relevance statement
AI can differentiate pathological changes within pectoral muscle tissue by assessing radiological images and maybe a potential diagnostic tool for detecting diabetes mellitus and other diseases that affect muscle tissues.
Key points
• AI may have an opportunistic use as a screening exam for diabetes during digital breast tomosynthesis.
• This technique allows for early and non-invasive detection of diabetes mellitus by AI.
• AI may have broad applications in detecting pathological changes within muscle tissue.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Boyko EJ, Magliano DJ, Karuranga S, Piemonte L, Saeedi PRP, Sun H. (2021) IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation.
2. Cusick M, Meleth AD, Agrón E et al (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes. Diabetes Care 28:617–625
3. Cobo A, Vázquez LA, Reviriego J, Rodríguez-Manas L (2016) Impact of frailty in older patients with diabetes mellitus: an overview. Endocrinol Nutr 63:291–303
4. Nishikawa H, Fukunishi S, Asai A, et al. (2021) Sarcopenia, frailty, and type 2 diabetes mellitus (Review). Mol Med Rep 24:854
5. Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ (2014) Frailty, sarcopenia, and diabetes. J Am Med Dir Assoc 15:853–859